Gladius Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,491
| Closed | -$28.4K | – | 51 |
|
|
2024
Q3 | $28.4K | Sell |
8,491
-337
| -4% | -$1.13K | ﹤0.01% | 203 |
|
|
2024
Q2 | $29.2K | Buy |
8,828
+288
| +3% | +$953 | ﹤0.01% | 227 |
|
|
2024
Q1 | $34.5K | Buy |
+8,540
| New | +$34.5K | 0.01% | 217 |
|
|
2023
Q4 | – | Sell |
-8,581
| Closed | -$25.7K | – | 236 |
|
|
2023
Q3 | $25.7K | Buy |
8,581
+4,251
| +98% | +$12.8K | ﹤0.01% | 236 |
|
|
2023
Q2 | $16.2K | Sell |
4,330
-3,383
| -44% | -$12.7K | ﹤0.01% | 225 |
|
|
2023
Q1 | $25.8K | Sell |
7,713
-200
| -3% | -$670 | ﹤0.01% | 224 |
|
|
2022
Q4 | $38.1K | Buy |
7,913
+3,064
| +63% | +$14.7K | ﹤0.01% | 185 |
|
|
2022
Q3 | $28K | Buy |
+4,849
| New | +$28K | ﹤0.01% | 253 |
|